Utah Medical Products Inc (NASDAQ: UTMD) has reported earnings for its fourth fiscal quarter (ending December 31) of $0.86 versus $1.18 for the same period a year ago — a decline of -27%. For the latest four quarters through December 31, E.P.S. were $3.96 versus $4.58 for the same period a year ago — a decline of -14%.
Recent Price Action
On 1/28/25, Utah Medical Products Inc (NASDAQ: UTMD) stock declined modestly by -1.8%, closing at $63.00. Moreover, trading volume in this decline was unusually high at 157% of normal. Relative to the market the stock has been weak over the last nine months but has risen 1.4% during the last week.
Current PriceTarget Research Rating
Utah Medical Products has a current Value Trend Rating of D (Negative). This rating combines consistent signals from two proprietary PTR measures of a stock’s attractiveness. Utah Medical Products has a neutral Appreciation Score of 46 and a slightly negative Power Rating of 32, leading to the Negative Value Trend Rating.
Rating Review
In light of this new information we are reviewing our current Overall Rating of D. This review will be completed in the next several days.
Be the first to comment